Neuland Labs

Official Entity • India (Hyderabad)

Indian CDMO with dedicated peptide manufacturing facility opening summer 2026. SPPS, LPPS, and hybrid peptide synthesis. USFDA/EMA/PMDA inspected. 6,370L reactor capacity in first module. Over 40 years of complex API development experience.

Official Website Report Discrepancy

Verification Summary

ConfidenceHigh

Business TypeCDMO

ModelManufacturer

RegionAsia

Founded1984

Verification status based on publicly available information and supplier-provided materials.

Products & Categories

Products

custom peptide synthesis peptide APIs GLP-1 APIs modified peptides peptide process development cGMP peptide manufacturing

Capabilities

Custom Synthesis Peptide APIs Oligonucleotides Manufacturing

Categories

CDMO pharmaceutical

Quality & Logistics

GMP Certified In-House Production International Shipping COAs Available

Is this your company?

Claim this listing to update your information, respond to buyer inquiries, and get a verified badge.

Update your company details and products
Get a verified supplier badge
Receive buyer inquiries from our directory

Claim This Listing

Free to claim. Verified upgrades available.